SI9300365A - New alkenes and alkines phoshat derivates, process for their preparation and use thereof as medicine - Google Patents

New alkenes and alkines phoshat derivates, process for their preparation and use thereof as medicine Download PDF

Info

Publication number
SI9300365A
SI9300365A SI9300365A SI9300365A SI9300365A SI 9300365 A SI9300365 A SI 9300365A SI 9300365 A SI9300365 A SI 9300365A SI 9300365 A SI9300365 A SI 9300365A SI 9300365 A SI9300365 A SI 9300365A
Authority
SI
Slovenia
Prior art keywords
methanol
mmol
phosphate
ammonia
preparation
Prior art date
Application number
SI9300365A
Other languages
Slovenian (sl)
Other versions
SI9300365B (en
Inventor
Gerhard Noessner
Bernhard Kutscher
Juergen Engel
Wolfgang Schumacher
Jurij Stekar
Peter Hilgard
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of SI9300365A publication Critical patent/SI9300365A/en
Publication of SI9300365B publication Critical patent/SI9300365B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • C07F9/106Adducts, complexes, salts of phosphatides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532Seven-(or more) membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Abstract

Novel phospholipid derivatives, preparation processes therefor and their use as medicaments are described.

Description

Evropska patentna prijava 108 565 obravnava spojine s splošno formuloEuropean Patent Application 108 565 deals with compounds of general formula

R1 (O)n - P - OCH2CH2N - R3 I \ 4 in njihove farmacevtsko uporabne soli, pri čemer je R1 alifatski ostanek ogljikovodika z 8 do 30 C-atomi, ostanki R2, R3 in R4 so enaki ali pa različni nižji alkilni ostanki ali vodiki, ali pri čemer pomeni skupina NR2R3R4 ciklično amonijakovo skupino in ima n vrednost 0 ali 1. Za te spojine sta biliR 1 (O) n - P - OCH2CH2N - R 3 I \ 4 and their pharmaceutically useful salts, wherein R 1 is an aliphatic hydrocarbon residue having 8 to 30 C atoms, the residues R2, R 3 and R 4 being the same or different lower alkyl residues or hydrogen, or wherein the NR 2 R 3 R 4 group is a cyclic ammonia group and n has a value of 0 or 1. For these compounds,

-2navedeni anti tumorsko in glivično zaviralno učinkovanje.-2These anti-tumor and fungal inhibitory effects.

Izum zadeva alkilne ali alkenske fosfate, katerih ostanek holina je del heterocikličnega obroča, postopek priprave razreda spojin, kot tudi zdravilnega sredstva in postopek za pripravo zdravilnih sredstev, ki vsebujejo te spojine kot aktivne sustance.The invention relates to alkyl or alkene phosphates, the choline residue of which is part of a heterocyclic ring, a process for the preparation of a class of compounds as well as a therapeutic agent, and a method for the preparation of therapeutic agents containing these compounds as active constituents.

Presenetljivo imajo spojine po izumu boljše anti tumorsko delovanje kot derivati z odprto verigo, opisani v EP-A108 565.Surprisingly, the compounds of the invention have better anti-tumor activity than the open-chain derivatives described in EP-A108 565.

Izum zadeva tudi ravnanje pri pripravi in ravnanje pri čiščenju novih spojin.The invention also relates to the preparation and handling of new compounds.

Prva stopnja priprave je reakcija fosforoksiklorida z dolgoverižnim alkoholom v halogenirane ali aromatske ogljikovodike, nasičene ciklične etre ali aciklične etre.The first stage of preparation is the reaction of phosphorous hydrochloride with long-chain alcohol into halogenated or aromatic hydrocarbons, saturated cyclic ethers or acyclic ethers.

Prva stopnja priprave A je reakcija fosforoksiklorida z dolgoverižnim alkoholom v halogenirane ogljikovodike, nasičene ciklične etre, aciklične etre, nasičene ogljikovodike s 5 do 10 C-atomi, tekoče aromatske ogljikovidike, ki so lahko substituirani tudi s halogeni (še zlasti s klorom) ali pa v mešanicah iz predhodno omenjenih topil oziroma brez topil, v danem primeru v navzočnosti za to običanih bazičnih substanc.The first stage of preparation A is the reaction of phosphorus oxychloride with long-chain alcohol into halogenated hydrocarbons, saturated cyclic ethers, acyclic ethers, saturated hydrocarbons having 5 to 10 C atoms, liquid aromatic hydrocarbons which may also be substituted by halogens (in particular chlorine) or in mixtures of the aforementioned solvents or solvents, optionally in the presence of the usual basic substances.

Kot halogenirani ogljikovodiki pridejo v poštev na primer ogljikovodiki z 1 do 6 C-atomi, pri čemer so eden, več ali vsi vodikovi atomi zamenjani s klorovimi atomi. Uporabljeni so lahko na primer metilenklorid, kloroform, etilenklorid, klorbenzol ali diklorbenzol. Če gre za s halogeni substituirane aromatske ogljikovodike, so ti substituirani prednostno z enim ali dvemaFor example, halogenated hydrocarbons include hydrocarbons having 1 to 6 C atoms, with one, more or all of the hydrogen atoms being replaced by chlorine atoms. For example, methylene chloride, chloroform, ethylene chloride, chlorobenzene or dichlorobenzene may be used. In the case of halogen substituted aromatic hydrocarbons, these are preferably substituted by one or two

-3atomoma halogena.-3 halogen atoms.

Kot nasičeni ciklični eter je lahko na primer uporabljen eter z velikostjo obroča 5 do 6, ki sestoji iz ogljikovih in enega ali dveh kisikovih atomov. Primera za to sta tetrahidrofuran in dioksan.For example, as a saturated cyclic ether, an ether having a ring size of 5 to 6 consisting of carbon and one or two oxygen atoms may be used. Tetrahydrofuran and dioxane are examples of this.

Aciklični etri sestojijo iz 2 do 8 ogljikovih atomov in so tekoči. V poštev pridejo na primer dietileter, diizobutileter metil-tetra-butil eter, diizopropileter.Acyclic ethers consist of 2 to 8 carbon atoms and are liquid. For example, diethyl ether, diisobutyl ether methyl-tetra-butyl ether, diisopropyl ether are considered.

Kot nasičeni ogljikovodiki pridejo v poštev nerazvejani in razvejani ogljikovodiki, ki sestojijo iz 5 do 10 ogljikovih atomov in so tekoči.As saturated hydrocarbons, unbranched and branched hydrocarbons consisting of 5 to 10 carbon atoms are liquid.

V poštev pridejo na primer pentan, heksan, heptan in cikloheksan.For example, pentane, hexane, heptane and cyclohexane are considered.

Kot aromatski ogljikovodiki pridejo v poštev na primer benzol in benzoli, substituirani z alkili, pri čemer sestojijo alkilne substituente iz 1 do 5 ogljikovih atomov.As aromatic hydrocarbons, for example, benzene and alkyl substituted benzenes are used, with alkyl substituents consisting of 1 to 5 carbon atoms.

Kot bazične substance tako za reakcijo fosforoksikloridov z dolgoverižnimi alkoholi kot tudi za temu sledečo pretvorbo v diester fosforove kisline pridejo v poštev amini, na primer alifatski amini s formulo NR1R2R3, pri čemer so R1, R2 in R3 enaki ali različni in pomenijo vodik ali C1 -Ce-alkile, lahko pa so tudi aromatski amini kot piridin, pikolin, kinolin. Pri spremembi v diester fosforove kisline so lahko dodane potrebne bazične substance istočasno ali pa pred aminoalkoholom oziroma soljo aminoalkohola.As basic substances, amines, for example, aliphatic amines of the formula NR1R2R3, for which R1, R2 and R3 are the same or different and represent hydrogen or C1 - are suitable for the reaction of phosphorus oxychlorides with long-chain alcohols and the subsequent conversion to phosphorous acid diester. Ce-alkyl, but may also be aromatic amines such as pyridine, picoline, quinoline. When converted to phosphoric acid diester, the necessary basic substances may be added at the same time or before the amino alcohol or salt of the amino alcohol.

V vsakem primeru je za to reakcijo potrebno topilo, to pomeni, da se mora dodati posebno topilo kasneje, če je prvi korak reakcije potekal brez le-tega. Molsko razmere fosforoksiklorida in dolgoverižnega alkohola je npr.In any case, a solvent is required for this reaction, which means that a special solvent must be added later if the first step of the reaction has taken place without it. The mole conditions of phosphoroxychloride and long-chain alcohol are e.g.

-4med 1,5:1 in 0,8:1. Aminoalkohol, oziroma sol aminoalkohola se v danem primeru dodaja v prevbitku glede na dolgoverižni alkohol (pribl. 1,1 do 1,5 molarni prebitek). Če reakcija fosforoksiklorindaav z dolgoverižnim alkoholom poteka v navzočnosti bazične substance, je količina bazične substance na primer 1 do 3 mole na 1 mol POCI3. Za pretvorbo v diester fosforove kisline, ki sledi, je uporabljena količina bazične substance na primer 1 do 5 molov na 1 mol.-4 between 1.5: 1 and 0.8: 1. The amino alcohol or salt of the amino alcohol is optionally added in excess of the long-chain alcohol (about 1.1 to 1.5 molar excess). If the reaction of phosphoroxychlorindaav with long-chain alcohol takes place in the presence of a basic substance, the amount of the basic substance, for example, is 1 to 3 moles per 1 mole of POCI3. For conversion to the phosphoric acid diester that follows, an amount of basic substance, for example 1 to 5 moles per 1 mol, is used.

Temperatura reakcije pretvorbe fosforoksiklorida z dolgoverižnim alkoholom leži med -30°C in +30°C, prednostno med -15°C in +5°C, še posebej pa med -10°C in -5°C.The reaction temperature of the conversion of phosphoroxychloride to long-chain alcohol is between -30 ° C and + 30 ° C, preferably between -15 ° C and + 5 ° C, and in particular between -10 ° C and -5 ° C.

Čas reakcije te pretvorbe znaša na primer med 0,5 in 5 urami, prednostno med 1 in 3 urami, še posebej pa med 1,5 in 2 urama. Če reakcija poteka v navzočnosti bazične substance, poteče v splošnem hitreje (v približno 30 minutah).For example, the reaction time of this conversion is between 0.5 and 5 hours, preferably between 1 and 3 hours, and especially between 1.5 and 2 hours. If the reaction takes place in the presence of a basic substance, it generally expires faster (in about 30 minutes).

Po tem je aminoalkohol oziroma sol aminoalkohola dodana po delih oziroma v celoti.Subsequently, the amino alcohol or salt of the amino alcohol is added in part or in full.

Kot soli aminoalkohola pridejo v poštev soli z mineralnimi kislinami (kot na primer žveplena kislina, solna kislina), nadalje soli z organskimi kislinami, kot na primer z ocetno kislino, para-toluolsulfonsko kislino in podobnimi. Ta korak reakcije poteka v inertnem topilu. Kot topila pridejo tukaj v poštev ista topila, kot so bila uporabljena pri pretvorbi fosforoksiklorida z dolgoverižnim alkoholom, če se je ta pretvorba odvijala v topilu.Salts with mineral acids (such as sulfuric acid, hydrochloric acid) and salts with organic acids such as acetic acid, para-toluenesulfonic acid and the like are considered salts of aminoalcohols. This reaction step is carried out in an inert solvent. The solvents used herein are those of the same solvents as those used in the conversion of phosphorus oxychloride to long-chain alcohol, if this conversion took place in the solvent.

Nato je bazična substanca raztopljena v enem od navedenih topil ali pa ukapljena brez topila. Prednostno se kot topila za bazične substanceThe basic substance is then dissolved in one of the solvents mentioned or liquefied without solvent. Preferably, they are solvents for basic substances

-5tukaj uporabljajo: halogenirani ogljikovodiki, nasičeni ciklični etri, aciklični etri, nasičeni ogljikovodiki s 5 do 10 ogljikovimi atomi, tekoči aromatski ogljikovodiki ali mešanice iz predhodno omenjenih topil.-5Here used here: halogenated hydrocarbons, saturated cyclic ethers, acyclic ethers, saturated hydrocarbons having 5 to 10 carbon atoms, liquid aromatic hydrocarbons or mixtures of the foregoing solvents.

Tukaj gre za ista topila kot jih lahko uporabljamo za pretvorbo fosforoksiklorida z dolgoverižnim alkoholom.These are the same solvents as can be used to convert phosphorous hydrochloride with long-chain alcohol.

Zaradi dodatka bazične substance se poviša temperatura. Skrbeti je treba za to, da se vzdržuje temperatura med 0°C in 40°C, prednostno med 10°C in 25°C, še najbolje pa med 15°C in 20°C.The addition of the basic substance raises the temperature. Care must be taken to maintain the temperature between 0 ° C and 40 ° C, preferably between 10 ° C and 25 ° C, and most preferably between 15 ° C and 20 ° C.

Reakcijska mešanica je nato premešana pri 5°C do 30°C, prednostno med 15°C in 30°C (na primer 1 uro do 40 ur, prednostno 3 do 15 ur.)The reaction mixture is then stirred at 5 ° C to 30 ° C, preferably between 15 ° C and 30 ° C (for example, 1 hour to 40 hours, preferably 3 to 15 hours.)

Hidroliza začetka reakcije se zgodi zaradi dodatka vode, pri čemer je treba vzdrževati temperaturo med 10°C in 30°C, prednostno med 15°C in 30°C, še najbolje pa med 15°C in 20°C.Hydrolysis of the initiation of the reaction occurs due to the addition of water, maintaining a temperature between 10 ° C and 30 ° C, preferably between 15 ° C and 30 ° C, and most preferably between 15 ° C and 20 ° C.

Predhodno omenjene hidrolizne tekočine lahko vsebujejo tudi bazične substance. Kot take bazične substance pridejo v poštev karbonati in hidrogenkarbonati alkalijskih in zemeljskih alkalijskih kovin.The hydrolysis fluids mentioned above may also contain basic substances. As such basic substances, carbonates and hydrogen carbonates of alkali and alkaline earth metals are considered.

Za izpopolnitev hidrolize se nato meša še 0,5 ure do 4 ure, prednostno 1 do 3 ure, še nabolje pa 1,5 do 2,5 ur pri 10°C do 30°C, prednostno pri 15°C do 25°C, še najbolje pa pri 18°C do 22°C.For further hydrolysis, it is further stirred for 0.5 hours to 4 hours, preferably 1 to 3 hours, and preferably 1.5 to 2.5 hours at 10 ° C to 30 ° C, preferably 15 ° C to 25 ° C. and preferably at 18 ° C to 22 ° C.

Reakcijsko raztopino se nato spere z mešanico iz vode in alkoholov (prednostno alifatski nasičeni alkoholi z 1 do 4 ogljikovimi atomi), ki lahko v danem primeru vsebuje še bazično substanco. Mešalno razmerje voda: alkohol lahko leži na primer med 5 in 0,5, prednostno med 1 in 3 (V/V).The reaction solution is then washed with a mixture of water and alcohols (preferably aliphatic saturated alcohols of 1 to 4 carbon atoms), which may optionally contain a basic substance. The mixing ratio of water: alcohol may for example be between 5 and 0.5, preferably between 1 and 3 (V / V).

-6Kot bazične substance za spiralno tekočino pridejo v poštev na primer karbonati in hidrogenkarbonati alkalijskih in zemeljskih alkalijskih kovin, kot tudi amoniak (na primer vodna raztopina amonijaka). Zlasti je dana prednost topilu iz 3% natrijevega karbonata v vodi.-6As basic alkaline substance substances, for example, are carbonates and hydrogen carbonates of alkali and alkaline earth metals, as well as ammonia (for example aqueous ammonia solution). Particular preference is given to a solvent of 3% sodium carbonate in water.

V danem primeru se nato izvrši spiranje reakcijske raztopine s kislo raztopino. Kislo spiranje je koristno za odstranitev še ne pretvorjenih bazičnih delov reakcijske raztopine, zlasti pri uporabi metilenklorida kot topila.In this case, the reaction solution is then washed with an acid solution. Acidic rinsing is useful for removing the not yet converted basic portions of the reaction solution, especially when using methylene chloride as a solvent.

Spiralna raztopina sestoji iz mešanice iz vode in alkoholov. Zlasti pridejo v poštev mešanice iz alifatskih nasičenih alkoholov z 1 do 4 ogljikovimi atomi, pri čemer je v danem primeru lahko navzoča še kisla substanca. Mešalno razmerje voda: alkohol lahko leži na primer med 5 in 0,5, prednostno med 1 in 3 (V/V).The spiral solution consists of a mixture of water and alcohols. In particular, aliphatic saturated alcohol mixtures of 1 to 4 carbon atoms may be considered, with an acidic substance optionally present. The mixing ratio of water: alcohol may for example be between 5 and 0.5, preferably between 1 and 3 (V / V).

Kot kisle substance za spiralno tekočino pridejo v poštev na primer mineralne in organske kisline, na primer solna kislina, žveplena kislina, vinska kislina ali citronska kislina. Zlasti je dana prednost 10% raztopini solne kisline v vodi.Mineral and organic acids such as hydrochloric acid, sulfuric acid, tartaric acid, and citric acid, for example, may be considered acidic substances for a spiral fluid. In particular, 10% hydrochloric acid solution in water is preferred.

Spojino se še enkrat spere z mešanico vode in alkoholov. Prednostno pridejo v poštev mešanice iz alifatskih nasičenih alkoholov z 1 do 4 ogljikovimi atomi, pri čemer je v danem primeru lahko navzoča še bazična substanca. Mešalno razmerje voda: alkohol lahko leži na primer med 5 in 0,5, prednostno med 1 in 3.The compound is again washed with a mixture of water and alcohols. Preferably, mixtures of aliphatic saturated alcohols with 1 to 4 carbon atoms are preferred, with a basic substance being present, if appropriate. The mixing ratio of water: alcohol may be, for example, between 5 and 0.5, preferably between 1 and 3.

Sprane faze se nato združi in na običajen način posuši, nato pa se topilo odstrani (prednostno pod zmanjšanim pritiskom, na primer 5 do 100The washed phases are then combined and dried in the usual way and then the solvent is removed (preferably under reduced pressure, for example 5 to 100

-7mbar), v danem primeru po dodatku 150-1000 ml, prednostno 300-700 ml, še najbolje pa 450-550 ml alifatskega alkohola (nanašajoč se na 1 mol dela teže suhega produkta). Kot alkoholi pridejo v poštev predvsem nasičeni alifatski alkoholi z dolžino verige med 1 in 5 ogljikovimi atomi. Zlasti je kot alkoholoma pri tem dana prednost n-butanolu in izopropanolu. Ta alkoholna obdelava je namenjena popolni odstranitvi ostale vode in omogoči, da se tako izognemo penjenju.-7mbar), optionally after the addition of 150-1000 ml, preferably 300-700 ml, and most preferably 450-550 ml of aliphatic alcohol (referring to 1 mole of the dry product weight). Alcohols, in particular, are saturated aliphatic alcohols with a chain length of between 1 and 5 carbon atoms. In particular, n-butanol and isopropanol are preferred as alcohols. This alcohol treatment is designed to completely remove the remaining water and to avoid foaming.

Sledi lahko na primer nadaljnje čiščenje produkta, med katerim se surovi izdelek vroče raztopi v etanolu, zaostalo odfiltrira in obdela z ionskim izmenjevalcem v mešalnem sloju, kot na primer z amberlitom MB3 v etanolni raztopini. Namesto ionskega izmenjevalca v mešalnem sloju se lahko uporabijo tudi vsi trgovsko običajni bazični in kisli ionski izmenjevalci hkrati ali pa drug za drugim.For example, further purification of the product, during which the crude product is hot dissolved in ethanol, may be followed by filtration and treated with an ion exchanger in a mixing layer, such as, for example, MB3 amberlite in ethanol solution. Instead of an ion exchanger in the mixing layer, all commercially available basic and acidic ion exchangers can be used simultaneously or one after the other.

Raztopino se nato prekristalizira iz ketonov, kot na primer acetona ali metiletil ketonov, v nekaterih primerih zadostuje obdelovanje z zgoraj imenovanimi topili. Lahko je smotrno produkte čistiti s kolonsko kromatografijo, oziroma Flash-kromatografijo na silicijevem gelu. Kot tekoče sredstvo se na primer uporabi mešanica iz kloroforma, metilenklorida, metanola in 25% amoniakove raztopine.The solution is then recrystallized from ketones such as acetone or methylethyl ketones, in some cases treatment with the solvents mentioned above is sufficient. It may be expedient to purify the products by column chromatography or flash chromatography on silica gel. For example, a mixture of chloroform, methylene chloride, methanol and 25% ammonia solution is used as the liquid agent.

Postopek po varianti B sestoji v dodatnem alkiliranju produktov, pri njihovi zamenjavi aminoalkoholov z alkilirajočimi agenti. Kot alkiiirajoči agenti se lahko na primer uporabljajo metilester p-toluolsulfonske kisline ali dimetilsulfat. Kot topila pridejo v poštev prej našteta topila.The process according to variant B consists in the additional alkylation of the products, when they are replaced by amino alcohols with alkylating agents. For example, methylating p-toluenesulfonic acid or dimethylsulfate may be used as the alkylating agents. The solvents listed above are suitable as solvents.

Kot bazične substance se na primer lahko uporabljajo karbonatiFor example, carbonates may be used as basic substances

-8alkalijskih kovin. Do pretvorbe pride pri povišani temperaturi, na primer pri temperaturi vrelišča topila.-8 Alkali metals. The conversion occurs at elevated temperature, for example at the boiling point of the solvent.

Primeri:Examples:

Primer 1: označbe (lUPAC-nomenklatura)Example 1: designations (LUPAC nomenclature)

4-(((oktadeciloksi)hidroksifosfenil)oksi)-1,1 -dimetilpipiridin hidroksid v obliki soli4 - ((((octadecyloxy) hydroxyphosphphenyl) oxy) -1,1-dimethylpyridine hydroxide in salt form

Kratka označba:Short label:

oktadecil-(1,1-dimetilpipiridin-4-il)-fosfat C25H52NO4P (461.66) * 1/2 H2Ooctadecyl- (1,1-dimethylpyridin-4-yl) -phosphate C25H52NO4P (461.66) * 1/2 H 2 O

Priprava po varianti A:Preparation according to variant A:

10,3 ml (0,11 mol) fosforoksiklorida se doda v 100 ml kloroforma in ohladi na 5-10°C. V 30 minutah se k temu nakaplja med mešanjem 27,0 ml (0,10 mol) 1-oktadekanola, raztopljenega v 100 ml kloroforma in 35 ml piridina. Po 30 minutnem dodatnem mešanju pri 5-10°C se k temu doda10.3 ml (0.11 mol) of phosphoroxychloride is added to 100 ml of chloroform and cooled to 5-10 ° C. In addition, 27.0 ml (0.10 mol) of 1-octadecanol dissolved in 100 ml of chloroform and 35 ml of pyridine were added dropwise over 30 minutes. After stirring for 30 minutes at 5-10 ° C, it is added

39,1 g (0,13 mol) 4-hidroksi-1,1- dimetilpipiridinijevega tosilata naenkrat. Po dodatku 40 ml piridina in 30 ml DMF se meša še 24 h pri sobni temperaturi. Nato se hidrolizira s 15 ml vode, meša še 30 minut in spere organsko fazo vsakič z 200 ml vode/metanola (1:1), 3% Na2CO3/metanola (1:1) in nato še z vodo/metanolom (1:1). Volumen organske faze se zmanjša, ostanek pa vroče razpusti v 300 ml etanola in po ohladitvi filtrira. Filtrat se zmeša z 80 g ionskega izmenjevalca amberlita MB3, odfiltrira in nato se mu zmanjša volumen. Ostanek se prekristalizira iz 300 ml metiletil ketona, odnuča in v39.1 g (0.13 mol) of 4-hydroxy-1,1-dimethylpyridinium tosylate at a time. After the addition of 40 ml of pyridine and 30 ml of DMF, the mixture is stirred at room temperature for 24 hours. It is then hydrolyzed with 15 ml of water, stirred for a further 30 minutes and washed with an organic phase each time with 200 ml of water / methanol (1: 1), 3% Na2CO3 / methanol (1: 1) and then with water / methanol (1: 1). ). The volume of the organic phase is reduced and the residue is hot dissolved in 300 ml of ethanol and filtered after cooling. The filtrate was mixed with 80 g of MB3 amberlite ion exchanger, filtered off and then reduced in volume. The residue was recrystallized from 300 ml of methylethyl ketone, drained and evaporated

-9vakumu posuši preko P2O5. Izkoristek: 4,71 g (10%)-9 Vacuum dry over P2O5. Yield: 4.71 g (10%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 65,26% ed: 65.26% 11,63% 11,63% 2,62% 2,62% izr.: 64,38% Calc .: 64.38% 11,61% 11,61% 2,73% 2.73% 65,04% 65,04% 11,80% 11.80% 2,78% 2.78%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat v 25% amonijaku 70:40:10)Thin layer chromatogram: (chloroform / methanol / 1 M sodium acetate in 25% ammonia 70:40:10)

Rf=0,17 (1-butanol/led ocetna kislina/voda 40:10:10)Rf = 0.17 (1-butanol / ice acetic acid / water 40:10:10)

Rf=0,12Rf = 0.12

Tališče: 270-271 °C (razkroj)Melting point: 270-271 ° C (decomposition)

Priprava po varianti B:Preparation by variant B:

20,1 ml (0,22 mol) fosforoksikiorida se doda v 100 ml metilenklorida, ohladi na 5-10°C in med mešanjem v 30 minutah primeša v raztopino iz20.1 ml (0.22 mol) of phosphoroxy oxy chloride is added to 100 ml of methylene chloride, cooled to 5-10 ° C and stirred for 30 minutes in a solution of

54,1 g (0,20 mol) oktadekanola v 400 ml metilenklorida in 70,5 ml piridina. Po eni uri dodatnega mešanja se po kapljicah doda 29,9 g (0,26 mol) 4-hidroksi-1-metilpipiridina v 80 ml piridina. Po 3 urah mešanja pri 10°C se v mrzlem stanju hidrolizira s 30 ml vode in še eno uro meša. Organska faza54.1 g (0.20 mol) of octadecanol in 400 ml of methylene chloride and 70.5 ml of pyridine. After one hour of additional stirring, 29.9 g (0.26 mol) of 4-hydroxy-1-methylpyridine in 80 ml of pyridine are added dropwise. After stirring at 10 ° C for 3 hours, it is hydrolyzed with 30 ml of water in the cold state and stirred for an additional hour. Organic phase

-10se spere z vsakič 200 ml vode/metanola (1:1), 3 odstotno solno kislino/metanolom (1:1) in vodo/metanolom (1:1). Preko Na2SO4 posušeni organski fazi se z uparitvijo zmanjša volumen do motnosti in primeša 1 I metiletilketona. Kristalizat se prekristalizira iz 1 I metiletilketona, odnuča in posuši preko P2O5 v vakuumu.-10was washed with 200 ml of water / methanol (1: 1), 3% hydrochloric acid / methanol (1: 1) and water / methanol (1: 1) each time. The organic phase, dried over Na2SO4, is reduced by volume to a turbidity by evaporation and mixed with 1 I methylethylketone. The crystallizate was recrystallized from 1 I methylethyl ketone, filtered off and dried over P2O5 in vacuo.

Izkoristek: 54,1 g (60%) oktadecil-1-(1-metilpipiridin-4-il)-fosfatYield: 54.1 g (60%) octadecyl-1- (1-methylpyridin-4-yl) -phosphate

98,1 g (0,22 mol) oktadecil-(1-metilpipirdin-4-il)-fosfata se suspendira v 500 ml abs. etanola in segreje do vrenja. Pod protitokom se doda k temu v dveh urah osem delov izmenjaje v skupni vrednosti 71,8 g (0,39 mol) metilestra p-toluolsulfonske kisline in 26,5 g (0,19 mol) kalijevega karbonata. Po končanem dodajanju se segreva še eno uro pod protitokom. Po ohladitvi se odfiltrira, zmanjša volumen filtrata na polovico in primeša raztopini 150 g vlažnega ionskega izmenjevalca amberlita MB 3. Po dvournem mešanju se posrka preko kremenčeve pene/aktivnega oglja, filtratu se zmanjša volumen in kristalizira čez aceton. Kristalinična pogača se prekristalizira iz metiletilketona in posuši v vakuumu preko P2O5.98.1 g (0.22 mol) of octadecyl- (1-methylpiperidin-4-yl) -phosphate were suspended in 500 ml of abs. ethanol and heated to boiling. Eight parts were added under counter-flow to a total of 71.8 g (0.39 mol) of methyl ester of p-toluenesulfonic acid and 26.5 g (0.19 mol) of potassium carbonate over two hours. After the addition is complete, it is heated under counter-flow for another hour. After cooling, it is filtered off, the filtrate is reduced in half and mixed with a solution of 150 g of a wet MB III amberlite ion exchanger. After stirring for two hours, it is filtered off with silica foam / activated carbon, the filtrate is reduced in volume and crystallized over acetone. The crystalline cake was recrystallized from methylethylketone and dried in vacuo over P2O5.

Izkoristek: 46,1 g (46%) oktadecil-(1,1 -dimetilpipiridin-4-il)- fosfatYield: 46.1 g (46%) octadecyl- (1,1-dimethylpyridin-4-yl) - phosphate

-11 Elementarna analiza:-11 Elemental Analysis:

C C H H N N izm.: 65,26% ed: 65.26% 11,63% 11,63% 2,62% 2,62% izr.: 65,18% 65.18% 11,62% 11,62% 2,68% 2.68% 65,07% 65,07% 11,71% 11,71% 2,70% 2.70%

Tališče: 271-272°C (razkroj)Melting point: 271-272 ° C (decomposition)

Primer 2: heksadecil-pipirdin-4-il-fosfat C21H44NO4P (405,558)Example 2: Hexadecyl-piperidin-4-yl-phosphate C21H44NO4P (405,558)

7,1 ml (77 mmol) fosforoksiklorida se raztopi v 50 ml suhega tetrahidrofurana in po ohladitvi na 5-10°C med mešanjem po kapljicah doda raztopina 17 g (70 mmol) heksadekanola in 48 ml trietilamina v 150 ml tetrahidrofurana. Po končanem dodajanju se meša raztopina še 30 minut v ledeni kopeli in nato pusti, da pride na sobno temperaturo. 10,1 g (100 mmol) 4-pipiridinola se razpusti v 100 ml tetrahidrofurana, zmeša s 17 ml trietilamina in po kapljicah med mešanjem doda reakcijski raztopini, tako da temperatura ne preseže 40°C. Po končanem dodajanju se eno uro kuha pod protitokom. Še vročo raztopino se odfiltrira preko trietilamonijevega klorida in po ohladitvi med mešanjem doda led-2M-solno kislinski zmesi. Produkt, ki izpade pri ohlajevanju v hladilniku, se zmeša v metilenklorid,7.1 ml (77 mmol) of phosphoroxychloride were dissolved in 50 ml of dry tetrahydrofuran and, after cooling to 5-10 ° C, a solution of 17 g (70 mmol) of hexadecanol and 48 ml of triethylamine in 150 ml of tetrahydrofuran was added dropwise. After the addition is complete, the solution is stirred for an additional 30 minutes in an ice bath and then allowed to come to room temperature. 10.1 g (100 mmol) of 4-piperidinol are dissolved in 100 ml of tetrahydrofuran, mixed with 17 ml of triethylamine and added dropwise while stirring to the reaction solution so that the temperature does not exceed 40 ° C. After the addition is complete, it is cooked under counterflow for one hour. The still hot solution was filtered off over triethylammonium chloride and, after cooling, added ice-2M hydrochloric acid to the mixture while stirring. The product which fails to cool in the refrigerator is mixed into methylene chloride,

-12posuši preko MgSO4 in po zmanjšanju volumna kromatografira na silicijevem gelu z metilenkloridom/metanolom/25% amonijakom (70:30:5). Produkt vsebujoče frakcije se združijo in z uparitvijo se jim zmanjša volumen. Po prekristalizaciji iz metanola se posuši v vakuumu preko P2O5.-12 dried over MgSO4 and, after volume reduction, chromatographed on silica gel with methylene chloride / methanol / 25% ammonia (70: 30: 5). The product-containing fractions are combined and the volume is reduced by evaporation. After recrystallization from methanol, it is dried in vacuo over P2O5.

Izkoristek: 10,0 g (35%)Yield: 10.0 g (35%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 62,19% ed: 62.19% 10,94% 10.94% 3,45% 3.45% izr.: 65,15% 65.15% 11,14% 11,14% 3,54% 3.54% 62,41% 62,41% 11,19% 11.19% 3,34% 3.34%

Tankoplastni kromatogram: (kloroform/metanol/25% amonijak 70:20:10)Thin layer chromatogram: (chloroform / methanol / 25% ammonia 70:20:10)

Rf=0,42 (1-butanol/led ocetna kislina/voda 40:10:10)Rf = 0.42 (1-butanol / ice acetic acid / water 40:10:10)

Rf=0,33Rf = 0.33

-13Primer 3: heksadecil-(1,1 -dimetilpipiridiη-4-il)-fosfat C25H52NO4P (461,64) * H2O-13Example 3: Hexadecyl- (1,1-dimethylpiperidin-4-yl) -phosphate C25H52NO4P (461.64) * H 2 O

5,7 g (14 mmol) heksadecil-pipiridin-4-il-fosfata se raztopi v 100 ml metanola in zmeša z 11,6 g (84 mmol) kalijevega karbonata. Med temeljitim mešanjem se v 30 minutah dokaplja 4,0 ml (42 mmol) dimetilsulfata. Mešanica se meša še 4 ure pri 40°C, po ohladitvi se filtrira in se ji zmanjša volumen. Ostanek se obdela v acetonu in po posrkanju raztopi v 100 ml 96% etanola. Zraven se pripoji 15 g ionskega izmenjevalca amberlita MB 3 in meša 3 ure. Po odfiltraciji se zmanjša volumen in dvakrat prekristalizira iz metiletilketona. Posuši se v vakuumu preko P2O5.5.7 g (14 mmol) of hexadecyl-pyridin-4-yl-phosphate were dissolved in 100 ml of methanol and mixed with 11.6 g (84 mmol) of potassium carbonate. 4.0 ml (42 mmol) of dimethylsulfate were added dropwise over 30 minutes with thorough stirring. The mixture was stirred for a further 4 hours at 40 ° C, filtered and reduced in volume after cooling. The residue was treated with acetone and dissolved in 100 ml of 96% ethanol after shaking. Next, 15 g of MB 3 amberlite ion exchanger is attached and stirred for 3 hours. After filtration, the volume is reduced and recrystallized twice from methyl ethyl ketone. Dry under vacuum over P2O5.

Izkoristek: 3,70 g (61%)Yield: 3.70 g (61%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 61,17% ed: 61.17% 11,16% 11,16% 3,10% 3,10% izr.: 60,83% 60.83% 11,14% 11,14% 2,99% 2.99% 60,92% 60,92% 11,26% 11,26% 3,00% 3.00%

-14Tankoplastni kromatogram: (kloroform/metanol/25% amonijak 70:20:10)-14 Thin-layer chromatogram: (chloroform / methanol / 25% ammonia 70:20:10)

Rf=0,28 (1-butanol/led ocetna kislina/voda 40:10:10)Rf = 0.28 (1-butanol / ice acetic acid / water 40:10:10)

Rf=0,13Rf = 0.13

Tališče: 230°C (razkroj)Melting point: 230 ° C (decomposition)

Primer 4: erucil-(1,1 -dimetiIpipiridiη-4-il)-fosfat C29H58NO4P (515.765) * H2OExample 4: Erucyl- (1,1-dimethylpiperidin-4-yl) -phosphate C29H58NO4P (515.765) * H 2 O

10,3 ml (0,11 mol) fosforoksiklorida se doda 50 ml kloroforma in pri 5-10°C po kapljicah zmeša z raztopino iz 32,5 g (0,10 mol) erucilalkohola in 32 ml piridina v 100 ml kloroforma. Po pol ure dodatnega mešanja se doda naenkrat 39,1 g (0,13 mol) 4-hidroksi- 1,1-dimetilpipiridinijevega tosilata. Po dokapljevanju 40 ml piridina se pusti mešanico, da se ogreje do sobne temperature in se jo meša 3 ure. Nato se hidrolizira s 15 ml vode, meša še pol ure in spere z vsakega 100 ml vode/metanola (1:1), 3% raztopino natrijevega karbonata/metanolom (1:1), 3% citronsko kislino/metanolom (1:1) in vodo/metanolom (1:1). Po zmanjšanju volumna organsko fazo vsebujočega ostanka se le ta obdela z acetonom in nato raztopi v 150 ml 96% etanola. To raztopino se 3 ure meša z 20 g ionskega izmenjevalca amberlita MB 3 in čisto precedi čez kremenčevo peno. Po zmanjšanju volumna se na silicijevem gelu kromatografira s kloroformomAdd 50 ml of chloroform to 10.3 ml (0.11 mol) of phosphoroxychloride and mix dropwise at 5-10 ° C with a solution of 32.5 g (0.10 mol) of erucyl alcohol and 32 ml of pyridine in 100 ml of chloroform. After half an hour of additional stirring, 39.1 g (0.13 mol) of 4-hydroxy-1,1-dimethylpyridinium tosylate are added at once. After 40 ml of pyridine was added dropwise, the mixture was allowed to warm to room temperature and stirred for 3 hours. It is then hydrolyzed with 15 ml of water, stirred for another half hour and washed with each 100 ml of water / methanol (1: 1), 3% sodium carbonate / methanol solution (1: 1), 3% citric acid / methanol (1: 1) ) and water / methanol (1: 1). After reducing the volume, the organic phase of the residue is treated with acetone and then dissolved in 150 ml of 96% ethanol. This solution is stirred for 3 hours with 20 g of MB 3 amberlite ion exchanger and is filtered over silica foam. After volume reduction, chloroform is chromatographed on silica gel

-15/metanolom/25% amonijakom 70:40:10. Produkt vsebujoče frakcije se združijo in volumen se jim v vakumu zmanjša do suhosti.-15 / methanol / 25% ammonia 70:40:10. The product containing the fraction was combined and the volume was reduced to dryness in vacuo.

Izkoristek: 4,4 g (9%)Yield: 4.4 g (9%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 65,26% ed: 65.26% 11,63% 11,63% 2,62% 2,62% izr.: 64,38% Calc .: 64.38% 11,61% 11,61% 2,73% 2.73% 65,04% 65,04% 11,80% 11.80% 2,78% 2.78%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat v 25% amonijaku 70:20:10)Thin layer chromatogram: (chloroform / methanol / 1 M sodium acetate in 25% ammonia 70:20:10)

Rf=0,30Rf = 0.30

Primer 5: heksadecil-(1,1 -dimetiIpipiridiη-3-il)-fosfat C23H48NO4P (433.616) * H2OExample 5: Hexadecyl- (1,1-dimethylpiperidin-3-yl) -phosphate C23H48NO4P (433.616) * H2O

10,3 ml (0,11 mol) fosforoksiklorida se doda v 50 ml kloroforma in ohladi na 0-10°C. 24,2 g (0,10 mol) n-heksadeka-nola se raztopi v 100 ml kloroforma, primeša 32 ml piridina in v roku ene ure v mrzlem stanju10.3 ml (0.11 mol) of phosphoroxychloride is added to 50 ml of chloroform and cooled to 0-10 ° C. Dissolve 24.2 g (0.10 mol) of n-hexadeca-nol in 100 ml of chloroform, mix 32 ml of pyridine and freeze in one hour

-16dokaplja fosforoksikloridni raztopini. Po pol ure mešanja se naenkrat doda-16 drops of phosphoroxychloride solution. After half an hour of stirring, it is added at a time

39,2 g (0,13 mol) 3-hidroksi-1,1- dimetilpipiridinijevega tosilata in dokaplja na sobni temperaturi v 15 minutah 40 ml piridina. Po 16 urah mešanja pri sobni temperaturi se hidrolizira s 15 ml vode, meša pol ure in spere z vsakega 100 ml vode/metanola (1:1), 3% raztopine natrijevega karbonata/metanola (1:1), 3% citronsko kislino/metanola (1:1) in vode/metanola (1:1). Organski fazi se po osušitvi zmanjša volumen preko natrijevega sulfata. Ostanek se raztopi v 150 ml 96% etanola, filtrira in zmeša filtrat z ionskim izmenjevalcem amberlitom MB 3. Po odfiltraciji ionskega izmenjevalca se volumen zmanjša, ostanek se kristalizira z acetonom in po odsesanju osuši v vakuumu preko P2O5.39.2 g (0.13 mol) of 3-hydroxy-1,1-dimethylpyridinium tosylate were added dropwise at room temperature over 40 minutes 40 ml of pyridine. After stirring at room temperature for 16 hours, it is hydrolyzed with 15 ml of water, stirred for half an hour and washed with each 100 ml of water / methanol (1: 1), 3% sodium carbonate / methanol solution (1: 1), 3% citric acid / methanol (1: 1) and water / methanol (1: 1). After drying, the organic phase is reduced in volume over sodium sulfate. The residue was dissolved in 150 ml of 96% ethanol, filtered and the filtrate was mixed with an MB III ion exchange amberlite.

Izkoristek: 13,5 g (31%)Yield: 13.5 g (31%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 61,17% ed: 61.17% 11,16% 11,16% 3,10% 3,10% izr.: 60,78% calc .: 60.78% 11,41% 11,41% 2,87% 2.87% 60,85% 60,85% 11,31% 11,31% 2,86% 2.86%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat v 25% amonijaku 70:40:10)Thin layer chromatogram: (chloroform / methanol / 1 M sodium acetate in 25% ammonia 70:40:10)

Rf=0,37Rf = 0.37

-17Primer 6: oktadecil-(1,1 -dimetilpipiridin-3-il)-fosfat-17Example 6: Octadecyl- (1,1-dimethylpyridin-3-yl) -phosphate

C25H52NO4P (461,670) * 1/2 H2OC25H52NO4P (461,670) * 1/2 H2O

Priprava je analogna primeru 5 iz 10,3 ml (0,11 mol) fosforoksiklorida, 27,0 g (0,10 mol) oktadekanola, 32 + 40 ml piridina in 39,2 g (0,13 mol) 3-hidroksi-1,1 - dimetiipipiridinskega tosilata.The preparation is analogous to Example 5 of 10.3 ml (0.11 mol) of phosphoroxychloride, 27.0 g (0.10 mol) of octadecanol, 32 + 40 ml of pyridine and 39.2 g (0.13 mol) of 3-hydroxy- 1,1 - dimethipipyridine tosylate.

Izkoristek: 18,7 g (40%)Yield: 18.7 g (40%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 63,80% ed: 63.80% 11,35% 11,35% 2,98% 2.98% izr.: 63,38% Calc .: 63.38% 11,72% 11,72% 2,63% 2,63% 63,61% 63,61% 11,98% 11,98% 2,61% 2.61%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat v 25% amonijaku 70:40:10)Thin layer chromatogram: (chloroform / methanol / 1 M sodium acetate in 25% ammonia 70:40:10)

Rf=0,35Rf = 0.35

-18Primer 7: heksadecil-(1,1 -dimetilpipiridin-2-il)metil-fosfat-18Example 7: Hexadecyl- (1,1-dimethylpyridin-2-yl) methyl phosphate

C24H50NO4P (447,643) * 1/2 H2OC24H50NO4P (447,643) * 1/2 H2O

Priprava je analogna primeru 5 iz 10,3 ml (0,11 mol) fosforoksiklorida,The preparation is analogous to Example 5 of 10.3 ml (0.11 mol) of phosphoroxychloride,

24,2 g (0,10 mol) heksadekanola, 32 + 40 ml piridina in 41,0 g (0,13 mol)24.2 g (0.10 mol) of hexadecanol, 32 + 40 ml of pyridine and 41.0 g (0.13 mol)

2-hidroksimetil-1,1 - dimetilpipiridinskega tosilata.2-Hydroxymethyl-1,1 - dimethylpyridinium tosylate.

Izkoristek: 22,9 g (51%)Yield: 22.9 g (51%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 63,13% changed: 63.13% 11,26% 11,26% 3,07% 3.07% izr.: 63,69% Calc .: 63.69% 11,73% 11,73% 3,04% 3.04% 63,75% 63,75% 11,71% 11,71% 3,04% 3.04%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat vThin layer chromatogram: (chloroform / methanol / 1 M sodium acetate v

25% amonijaku 70:40:10)25% ammonia 70:40:10)

Rf=0,47Rf = 0.47

-19Primer 8: oktadecil-(1,1 -dimetilpipiridin-2-il)metil-fosfat-19Example 8: Octadecyl- (1,1-dimethylpyridin-2-yl) methyl phosphate

C26H54NO4P (475,697) * 1/2 H2OC26H54NO4P (475,697) * 1/2 H2O

Priprava je analogna primeru 5 iz 10,3 ml (0,11 mol) fosforoksiklorida, 27,0 g (0,10 mol) oktadekanola, 32 + 40 ml piridina in 41,0 g (0,13 mol) 2-hidroksimetil-1,1- dimetilpipiridinskega tosilata.The preparation is analogous to Example 5 of 10.3 ml (0.11 mol) of phosphoroxychloride, 27.0 g (0.10 mol) of octadecanol, 32 + 40 ml of pyridine and 41.0 g (0.13 mol) of 2-hydroxymethyl- 1,1- dimethylpyridinium tosylate.

Izkoristek: 23,9 g (50%)Yield: 23.9 g (50%)

Elementarna analiza:Elemental analysis:

C C H H N N izm. :64,43% Ed. : 64,43% 11,44% 11,44% 2,89% 2.89% izr.: 64,50% ex: 64.50% 11,61% 11,61% 2,67% 2.67% 64,11% 64,11% 11,49% 11,49% 2,77% 2.77%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat vThin layer chromatogram: (chloroform / methanol / 1 M sodium acetate v

25% amonijaku 70:40:10)25% ammonia 70:40:10)

Rf=0,47Rf = 0.47

-20Primer 9: heksadecil-(1,1 -dimetilpipiridin-3-il)metil-fosfat-20Example 9: Hexadecyl- (1,1-dimethylpyridin-3-yl) methyl phosphate

C24H50NO4P (447,643) * 1 H2OC24H50NO4P (447,643) * 1 H2O

Priprava je analogna primeru 5 iz 10,3 ml (0,11 mol) fosforoksiklorida,The preparation is analogous to Example 5 of 10.3 ml (0.11 mol) of phosphoroxychloride,

24,2 g (0,10 mol) heksadekanola, 32 + 40 ml piridina in 41,0 g (0,13 mol)24.2 g (0.10 mol) of hexadecanol, 32 + 40 ml of pyridine and 41.0 g (0.13 mol)

3-hidroksimetil-1,1 - dimetilpipiridinskega tosilata.3-Hydroxymethyl-1,1 - dimethylpyridinium tosylate.

Izkoristek: 17,2 g (39%)Yield: 17.2 g (39%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 61,91% ed: 61.91% 11,26% 11,26% 3,01% 3,01% izr.: 62,32% 62.32% 12,21% 12,21% 2,86% 2.86% 61,79% 61,79% 11,96% 11,96% 2,98% 2.98%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat vThin layer chromatogram: (chloroform / methanol / 1 M sodium acetate v

25% amonijaku 70:40:10)25% ammonia 70:40:10)

Rf=0,29Rf = 0.29

-21 Primer 10: oktadecil-(1,1-dimetilpipiridin-3-il)metil-fosfat-21 Example 10: octadecyl- (1,1-dimethylpyridin-3-yl) methyl phosphate

C26H54NO4P (475,697) * H2OC26H54NO4P (475.697) * H 2 O

Priprava je analogna primeru 5 iz 10,3 ml (0,11 mol) fosforoksiklorida, 27,0 g (0,10 mol) oktadekanola, 32 + 40 ml piridina in 41,0 g (0,13 mol) 3-hidroksimetil-1,1 - dimetilpipiridinskega tosilata.The preparation is analogous to Example 5 of 10.3 ml (0.11 mol) of phosphoroxychloride, 27.0 g (0.10 mol) of octadecanol, 32 + 40 ml of pyridine and 41.0 g (0.13 mol) of 3-hydroxymethyl- 1,1 - dimethylpyridine tosylate.

Izkoristek: 16,7 g (35%)Yield: 16.7 g (35%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 63,25% ed: 63.25% 11,43% 11,43% 2,84% 2.84% izr.: 62,98% 62.98% 12,21% 12,21% 2,76% 2.76% 63,67% 63,67% 12,47% 12,47% 2,80% 2.80%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat vThin layer chromatogram: (chloroform / methanol / 1 M sodium acetate v

25% amonijaku 70:40:10)25% ammonia 70:40:10)

Rf=0,30Rf = 0.30

-22Primer 11: tetradecil-(1,1-dimetilheksahidroazepin-4-il)-fosfat-22Example 11: tetradecyl- (1,1-dimethylhexahydroazepin-4-yl) -phosphate

C22H46NO4P (419,54) * H2OC22H46NO4P (419.54) * H2O

Priprava je analogna primeru 5 iz 9,6 ml (45 mmol) tetradekanola, 4,6 ml (50 mmol) fosforoksiklorida, 10 + 20 ml piridina in 21,3 g (67,5 mmol) hidroksi-1,1- dimetilheksahidroazepinovega tosilata. Čiščenje s Flash-kromatografijo na silicijevem gelu z metilenkloridom/metanolom/25% amonijakom 70:40:10.The preparation is analogous to Example 5 of 9.6 ml (45 mmol) tetradecanol, 4.6 ml (50 mmol) phosphoroxychloride, 10 + 20 ml pyridine and 21.3 g (67.5 mmol) hydroxy-1,1-dimethylhexahydroazepine tosylate . Purification by flash chromatography on silica gel with methylene chloride / methanol / 25% ammonia 70:40:10.

Izkoristek: 2,70 g (15%)Yield: 2.70 g (15%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 60,40% changed: 60.40% 11,05% 11.05% 3,20% 3,20% izr.: 60,47% calc .: 60.47% 11,29% 11,29% 3,63% 3,63% 60,78% 60,78% 11,52% 11.52% 3,68% 3,68%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat v 25% amonijaku 70:40:10)Thin layer chromatogram: (chloroform / methanol / 1 M sodium acetate in 25% ammonia 70:40:10)

Rf=0,30 (1-butanol/led ocetna kislina/voda 40:10:10)Rf = 0.30 (1-butanol / ice acetic acid / water 40:10:10)

Rf=0,08Rf = 0.08

-23Primer 12: heksadecil-(1,1-dimetilheksahidroazepin-4-il)-fosfat-23Example 12: Hexadecyl- (1,1-dimethylhexahydroazepin-4-yl) -phosphate

C24H48NO4P (445,62)C24H48NO4P (445,62)

Priprava je analogna primeru 5 iz 10,8 g (45 mmol) heksadekanola, 4,6 ml (50 mmol) fosforoksiklorida, 10 + 20 ml piridina in 21,3 g (67,5 mmol) 4-hidroksi-1,1- dimetilheksahidroazepinovega tosilata. Čiščenje s Flash-kromatografijo na silicijevem gelu z metilenkloridom/metanolom/25% amonijakom 70:30:10.The preparation is analogous to Example 5 of 10.8 g (45 mmol) of hexadecanol, 4.6 ml (50 mmol) of phosphoroxychloride, 10 + 20 ml of pyridine and 21.3 g (67.5 mmol) of 4-hydroxy-1,1- dimethylhexahydroazepine tosylate. Purification by flash chromatography on silica gel with methylene chloride / methanol / 25% ammonia 70:30:10.

Izkoristek: 5,0 g (25%)Yield: 5.0 g (25%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 64,69% ed: 64.69% 10,86% 10,86% 3,14% 3,14% izr.: 63,90% Calc .: 63.90% 11,54% 11.54% 3,22% 3,22% 64,08% 64,08% 11,59% 11.59% 3,24% 3.24%

Tankoplastni kromatogram: (kloroform/metanol/25% amonijak 80:25:5)Thin layer chromatogram: (chloroform / methanol / 25% ammonia 80: 25: 5)

Rf=0,10 (1-butanol/led ocetna kislina/voda 40:10:10)Rf = 0.10 (1-butanol / ice acetic acid / water 40:10:10)

Rf=0,10Rf = 0.10

Tališče: >250°C (razkroj)Melting point:> 250 ° C (decomposition)

-24Primer 13: oktadecil-(1,1-dimetilheksahidroazepin-4-il)-fosfat-24Example 13: Octadecyl- (1,1-dimethylhexahydroazepin-4-yl) -phosphate

C26H54NO4P (475,695) * 1/2 H20C26H54NO4P (475,695) * 1/2 H 2 0

Priprava je analogna primeru 5 iz 12,1 g (45 mmol) oktadekanola, 4,6 ml (50 mmol) fosforoksikiorida, 10 + 20 ml piridina in 21,3 g (67,5 mmol)The preparation is analogous to Example 5 of 12.1 g (45 mmol) of octadecanol, 4.6 ml (50 mmol) of phosphoxy oxy chloride, 10 + 20 ml of pyridine and 21.3 g (67.5 mmol)

4-hidroksi-1,1-dimetilheksahidroazepinovega tosilata. Čiščenje s Flash-kromatografijo na silicijevem gelu z metilenkloridom/metanolom/25% amonijakom 70:30:10.Of 4-hydroxy-1,1-dimethylhexahydroazepine tosylate. Purification by flash chromatography on silica gel with methylene chloride / methanol / 25% ammonia 70:30:10.

Izkoristek: 5,5 g (26%)Yield: 5.5 g (26%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 64,43% ed: 64.43% 11,44% 11,44% 2,89% 2.89% izr.: 64,54% ex: 64.54% 11,64% 11,64% 2,82% 2.82% 64,66% 64,66% 11,58% 11,58% 2,64% 2.64%

Tankoplastni kromatogram: (kloroform/metanol/1 M antrijev acetat v 25% amonijaku 70:40:10)Thin layer chromatogram: (chloroform / methanol / 1 M sodium acetate in 25% ammonia 70:40:10)

Rf=0,22Rf = 0.22

Tališče: >250°C (razkroj)Melting point:> 250 ° C (decomposition)

-25Primer 14: cis- A9-oktadecenil - (1,1-25Example 14: cis- A 9 -octadecenyl - (1,1

-dimetilheksahidroazepin-4-il)-fosfat-Dimethylhexahydroazepin-4-yl) -phosphate

C26H52NO4P (473,679) * H2OC26H52NO4P (473,679) * H2O

Priprava je analogna primeru 5 iz 12,1 g (45 mmol) cis- Δ9oktadecenola, 4,6 ml (50 mmol) fosforoksiklorida, 10 + 20 ml piridina in 21,3 g (67,5 mmol) 4-hidroksi-1,1- dimetilheksahidroazepinovegatosilata.The preparation is analogous to Example 5 of 12.1 g (45 mmol) of cis-Δ 9 octadecenol, 4.6 ml (50 mmol) of phosphoroxychloride, 10 + 20 ml of pyridine and 21.3 g (67.5 mmol) of 4-hydroxy- 1,1- dimethylhexahydroazepineoveatosilate.

Čiščenje s Flash-kromatografijo na silicijevem gelu z metilenkloridom/metanolom/25% amonijakom 70:30:10.Purification by flash chromatography on silica gel with methylene chloride / methanol / 25% ammonia 70:30:10.

Izkoristek: 4,5 g (21%) Elementarna analiza: Yield: 4.5 g (21%) Elemental analysis: C C H H N N izm.: 63,51% ed: 63.51% 11,07% 11,07% 2,85% 2.85% izr.: 64,05% Calc .: 64.05% 11,21% 11,21% 3,10% 3,10% 63,80% 63,80% 11,06% 11,06% 3,06% 3.06%

Tankoplastni kromatogram: (kloroform/metanol/25% amonijak 70:40:10)Thin layer chromatogram: (chloroform / methanol / 25% ammonia 70:40:10)

Rf=0,28 (1-butanol/led ocetna kislina/voda 40:10:10)Rf = 0.28 (1-butanol / ice acetic acid / water 40:10:10)

Rf=0,10Rf = 0.10

-26Primer 15: eikosil-(1,1-dimetilheksahidroazepino-4-il)-fosfat-26Example 15: Eicosyl- (1,1-dimethylhexahydroazepino-4-yl) -phosphate

C28H58NO4P (503,754) * H2OC28H58NO4P (503.754) * H2O

Priprava je analogna primeru 5 iz 13,4 g (45 mmol) eikosanola, 4,6 ml (50 mmol) fosforoksiklorida, 10 + 20 ml piridina in 21,3 g (67,5 mmol) 4-hidroksi-1,1-dimetilheksahidroazepinovega tosilata.The preparation is analogous to Example 5 of 13.4 g (45 mmol) of eicosanol, 4.6 ml (50 mmol) of phosphoroxychloride, 10 + 20 ml of pyridine and 21.3 g (67.5 mmol) of 4-hydroxy-1,1- dimethylhexahydroazepine tosylate.

Čiščenje s Flash-kromatografijo na silicijevem gelu z metilenkloridom/metanolom/25% amonijakom 70:30:10.Purification by flash chromatography on silica gel with methylene chloride / methanol / 25% ammonia 70:30:10.

Izkoristek: 5,7 g (25%)Yield: 5.7 g (25%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 64,46% ed: 64.46% 11,59% 11.59% 2,68% 2.68% izr.: 63,51% Calc .: 63.51% 11,48% 11,48% 2,95% 2.95% 64,00% 64,00% 11,79% 11,79% 2,91% 2.91%

Tankoplastni kromatogram: (kloroform/metanol/25% amonijakThin layer chromatogram: (chloroform / methanol / 25% ammonia

70:40:10)70:40:10)

Rf=0,12Rf = 0.12

-27Primer 16: erucil-(1,1-dimetilheksahidroazepin-4-il)-fosfat-27Example 16: Erucil- (1,1-dimethylhexahydroazepin-4-yl) -phosphate

C30H60NO4P (529,789) * H2OC30H60NO4P (529.789) * H2O

Priprava je analogna primeru 5 iz 16,2 g (50 mmol) erucilalkohola, 5,1 ml (55 mmol) fosforoksiklorida, 18 + 30 ml piridina in 20,5 g (65 mmol) 4-hidroksi-1,1- dimetilheksahidroazepinovega tosilata.The preparation is analogous to Example 5 of 16.2 g (50 mmol) of erucyl alcohol, 5.1 ml (55 mmol) of phosphoroxychloride, 18 + 30 ml of pyridine and 20.5 g (65 mmol) of 4-hydroxy-1,1-dimethylhexahydroazepine tosylate .

Čiščenje s Flash-kromatografijo na silicijevem gelu z metilenkloridom/metanolom/25% amonijakom 70:30:10.Purification by flash chromatography on silica gel with methylene chloride / methanol / 25% ammonia 70:30:10.

Izkoristek: 4,1 g (15%)Yield: 4.1 g (15%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 65,78% ed: 65.78% 11,41% 11,41% 2,56% 2,56% izr.: 65,76% 65.76% 12,01% 12.01% 2,97% 2.97% 65,82% 65,82% 11,63% 11,63% 2,96% 2.96%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat vThin layer chromatogram: (chloroform / methanol / 1 M sodium acetate v

25% amonijaku 70:40:10)25% ammonia 70:40:10)

Rf=0,30Rf = 0.30

-28Primer 17: oktadecil-(1,1-dimetilpirolidin-3-il)-fosfat-28Example 17: Octadecyl- (1,1-dimethylpyrrolidin-3-yl) -phosphate

C24H50NO4P (447,643) * 1/2 H2OC24H50NO4P (447,643) * 1/2 H2O

Priprava je analogna primeru 5 iz 3,25 g (12 mmol) oktadekanola, 1,21 ml (13 mmol) fosforoksiklorida, 3,7 + 4,8 ml piridina in 4,31 g (15 mmol) hidroksi-1,1-dimetilpirolidinskega tosilata.The preparation is analogous to Example 5 of 3.25 g (12 mmol) octadecanol, 1.21 ml (13 mmol) phosphoroxychloride, 3.7 + 4.8 ml pyridine and 4.31 g (15 mmol) hydroxy-1,1- dimethylpyrrolidine tosylate.

Čiščenje ostanka produkta z raztopitvijo v 96% etanolu in z obdelavo z ionskim izmenjevalcem amberlitom MB 3.Purification of the residue of the product by dissolving in 96% ethanol and treating it with an MB 3 ion exchange amberlite.

Izkoristek: 1,31 g (25%)Yield: 1.31 g (25%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 63,13% changed: 63.13% 11,26% 11,26% 3,07% 3.07% izr.: 62,99% 62.99% 11,28% 11,28% 2,80% 2.80% 62,74% 62,74% 11,27% 11,27% 2,89% 2.89%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat vThin layer chromatogram: (chloroform / methanol / 1 M sodium acetate v

25% amonijaku 70:40:10)25% ammonia 70:40:10)

Rf=0,25Rf = 0.25

-29Primer 18: heksadecil-2-(1,1-dimetilpirolidin-2-il) etil-fosfat C24H50NO4P (447,643) * H2O-29Example 18: Hexadecyl-2- (1,1-dimethylpyrrolidin-2-yl) ethyl phosphate C24H50NO4P (447,643) * H2O

Priprava je analogna primeru 5 iz 9,21 g (38 mmol) heksadekanola, 3,9 ml (42 mmol) fosforoksiklorida, 13 + 16 ml piridina in 15,8 g (50 mmol) 2-(2-hidroksietil)-1,1 - dimetilpirolidinskega tosilata.The preparation is analogous to Example 5 of 9.21 g (38 mmol) of hexadecanol, 3.9 ml (42 mmol) of phosphoroxychloride, 13 + 16 ml of pyridine and 15.8 g (50 mmol) of 2- (2-hydroxyethyl) -1. 1- dimethylpyrrolidine tosylate.

Čiščenje z raztopitvijo v 96% etanolu in z obdelavo z ionskim izmenjevalcem amberlitom MB 3.Purification by dissolving in 96% ethanol and treating with MB 3 amberlite ion exchanger.

Izkoristek: 6,0 g (35%)Yield: 6.0 g (35%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 61,91% ed: 61.91% 11,26% 11,26% 3,01% 3,01% izr.: 61,82% 61.82% 11,69% 11,69% 3,21% 3,21% 61,93% 61,93% 11,86% 11,86% 3,28% 3.28%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat vThin layer chromatogram: (chloroform / methanol / 1 M sodium acetate v

25% amonijaku 70:40:10)25% ammonia 70:40:10)

Rf=0,38Rf = 0.38

-30Primer 19: oktadecil-2-(1,1 -dimetilpiroIidin-2-il) etil-fosfat-30Example 19: Octadecyl-2- (1,1-dimethylpyrrolidin-2-yl) ethyl phosphate

C26H54NO4P (475,697) * 1/2 H2OC26H54NO4P (475,697) * 1/2 H 2 O

Priprava je analogna primeru 5 iz 10,3 g (38 mmol) oktadekanola, 3,9 ml (42 mmol) fosforoksiklorida, 13 + 16 ml piridina in 15,8 g (50 mmol) 2-(2-hidroksietil)-1,1- dimetilpirolidinskega tosilata.The preparation is analogous to Example 5 of 10.3 g (38 mmol) octadecanol, 3.9 ml (42 mmol) phosphoroxychloride, 13 + 16 ml pyridine and 15.8 g (50 mmol) 2- (2-hydroxyethyl) -1. 1- dimethylpyrrolidine tosylate.

Čiščenje z raztopitvijo v 96% etanolu in z obdelavo z ionskim izmenjevalcem amberlitom MB 3.Purification by dissolving in 96% ethanol and treating with MB 3 amberlite ion exchanger.

Izkoristek: 7,8 g (43%)Yield: 7.8 g (43%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 64,43% ed: 64.43% 11,44% 11,44% 2,89% 2.89% izr.: 64,69% Calc .: 64.69% 11,77% 11,77% 2,64% 2.64% 64,84% 64,84% 11,88% 11,88% 2,69% 2,69%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat vThin layer chromatogram: (chloroform / methanol / 1 M sodium acetate v

25% amonijaku 70:40:10)25% ammonia 70:40:10)

Rf=0,35Rf = 0.35

-31 Primer 20: heksadecil-(1,1 -dimetilpirolidin-2-il) metil-fosfat-31 Example 20: Hexadecyl- (1,1-dimethylpyrrolidin-2-yl) methyl phosphate

C23H48NO4P (433,616) * 1/2 H2OC23H48NO4P (433,616) * 1/2 H 2 O

Priprava je analogna primeru 5 iz 9,21 g (38 mmol) heksadekanola, 3,9 ml (42 mmol) fosforoksiklorida, 13 + 16 ml piridina in 15,1 g (50 mmol)The preparation is analogous to Example 5 of 9.21 g (38 mmol) of hexadecanol, 3.9 ml (42 mmol) of phosphoroxychloride, 13 + 16 ml of pyridine and 15.1 g (50 mmol)

2-hidroksimetil-1,1 - dimetilpirolidinskega tosilata.2-hydroxymethyl-1,1 - dimethylpyrrolidine tosylate.

Čiščenje z raztopitvijo v 96% etanolu in z obdelavo z ionskim izmenjevalcem amberlitom MB 3.Purification by dissolving in 96% ethanol and treating with MB 3 amberlite ion exchanger.

Izkoristek: 8,3 g (51%)Yield: 8.3 g (51%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 62,41% ed: 62.41% 11,16% 11,16% 3,16% 3,16% izr.: 62,09% 62.09% 11,48% 11,48% 3,01% 3,01% 62,25% 62,25% 11,66% 11,66% 3,09% 3.09%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat vThin layer chromatogram: (chloroform / methanol / 1 M sodium acetate v

25% amonijaku 70:40:10)25% ammonia 70:40:10)

Rf=0,33Rf = 0.33

-32Primer 21: oktadecil-(1,1-dimetilpirolidin-2-il) metil-fosfat-32Example 21: Octadecyl- (1,1-dimethylpyrrolidin-2-yl) methyl phosphate

C25H52NO4P (461,67) * 1/2 H2OC25H52NO4P (461.67) * 1/2 H2O

Priprava je analogna primeru 5 iz 10,3 g (38 mmol) oktadekanola, 3,9 ml (42 mmol) fosforoksiklorida, 13 + 16 ml piridina in 15,1 g (50 mmol) 2-hidroksimetil-1,1 - dimetilpirolidinskega tosilata.The preparation is analogous to Example 5 of 10.3 g (38 mmol) octadecanol, 3.9 ml (42 mmol) phosphoroxychloride, 13 + 16 ml pyridine and 15.1 g (50 mmol) 2-hydroxymethyl-1,1-dimethylpyrrolidine tosylate .

Čiščenje z raztopitvijo v 96% etanolu in z obdelavo z ionskim izmenjevalcem amberlitom MB 3.Purification by dissolving in 96% ethanol and treating with MB 3 amberlite ion exchanger.

Izkoristek: 9,0 g (52%)Yield: 9.0 g (52%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 63,80% ed: 63.80% 11,35% 11,35% 2,98% 2.98% izr.: 63,13% Calc .: 63.13% 11,57% 11.57% 2,84% 2.84% 63,55% 63,55% 11,66% 11,66% 2,82% 2.82%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat vThin layer chromatogram: (chloroform / methanol / 1 M sodium acetate v

25% amonijaku 70:40:10)25% ammonia 70:40:10)

Rf=0,35Rf = 0.35

-33Primer 22: heksadecil-(1 -metilkinuklidin-3-il)-fosfat-33Example 22: Hexadecyl- (1-methylquinuclidin-3-yl) -phosphate

C24H48NO4P (445,64) * 1,5 H2OC24H48NO4P (445.64) * 1.5 H2O

2,7 ml (30 mmol) fosforoksiklorida se razpusti v 25 ml kloroforma, ohladi na 5-10°C in po kapljicah v roku ene ure primeša raztopini iz 6,4 g (26 mmol) heksadekanola in 10 ml piridina v 50 ml kloroforma. Po pol ure dodatnega mešanja pri sobni temperaturi se doda raztopina iz 4,5 g (35 mmol) 3- hidroksikinuklidina in 5 ml piridina v 10 ml kloroforma. Po 5 urah mešanja pri temperaturi prostora se hidrolizira s 15 ml vode in še pol ure dodatno meša. Nato se spere dvakrat, z vsakič 100 ml vode/metanola (1:1) in zmanjša volumen organske faze po osušitvi preko magnezijevega sulfata do suhosti. Ostanek se kromatografira na silicijevem gelu z metilenkloridom/metanolom 80:25 in nato z metilenkloridom /metanolom/25% amonijakom 80:25:5. Produkt vsebujoče frakcije se očistijo, do suhosti uparijo in kristalizirajo z dodatkom acetona. Osušitev v vakuumu preko P2O5.Dissolve 2.7 ml (30 mmol) of phosphoroxychloride in 25 ml of chloroform, cool to 5-10 ° C and mix dropwise within one hour with a solution of 6.4 g (26 mmol) of hexadecanol and 10 ml of pyridine in 50 ml of chloroform . After stirring at room temperature for half an hour, a solution of 4.5 g (35 mmol) of 3-hydroxyquinuclidine and 5 ml of pyridine in 10 ml of chloroform was added. After stirring for 5 hours at ambient temperature, it is hydrolyzed with 15 ml of water and stirred an additional half hour. It is then washed twice, each time with 100 ml of water / methanol (1: 1) and reduced the volume of the organic phase after drying over magnesium sulfate to dryness. The residue is chromatographed on silica gel with methylene chloride / methanol 80:25 and then methylene chloride / methanol / 25% ammonia 80: 25: 5. The product-containing fractions were purified, evaporated to dryness and crystallized with acetone. Vacuum drying over P2O5.

Izkoristek: 4,95 (44%) heksadecil-(kinuklidin-3-il)-fosfatYield: 4.95 (44%) hexadecyl- (quinuclidin-3-yl) -phosphate

4,95 g (11,5 mmol) heksadecil-(kinuklidin-3-il)-fosfata se raztopi v 30 ml metanola in zmeša s 13,7 g (69 mmol) kalijevega karbonata, 8,5 ml vode ter po kapljicah med dobrim mešanjem z raztopino iz 3,3 ml (35 mmol) dimetilsulfata v 5 ml metanola. Po 14 urah mešanja pri temperaturi prostora4.95 g (11.5 mmol) of hexadecyl- (quinuclidin-3-yl) -phosphate is dissolved in 30 ml of methanol and mixed with 13.7 g (69 mmol) of potassium carbonate, 8.5 ml of water and dripped between mixing well with a solution of 3.3 ml (35 mmol) of dimethylsulfate in 5 ml of methanol. After stirring for 14 hours at room temperature

-34se prefiltrira preko organske soli, filtratu zmanjša volumen do suhosti in ostanek zmeša v metilenklorid. Po filtraciji se kromatografira na silicijevem gelu z metilenkloridom/metanolom/25% amonijakom 70:30:5. Produkt vsebujoče frakcije se združijo, do suhosti uparijo in kristalizirajo z dodatkom acetona. Osušitev v vakuumu preko P2O5.-34 is filtered through an organic salt, the filtrate is reduced to dryness and the residue is taken up in methylene chloride. After filtration, it is chromatographed on silica gel with methylene chloride / methanol / 25% ammonia 70: 30: 5. The product containing fractions were combined, evaporated to dryness and crystallized with acetone. Vacuum drying over P2O5.

Izkoristek: 2,7 g (49%)Yield: 2.7 g (49%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 60,99% ed: 60.99% 10,88% 10,88% 2,96% 2.96% izr.: 61,38% 61.38% 11,04% 11,04% 3,29% 3.29% 61,46% 61,46% 11,22% 11,22% 3,25% 3.25%

Tankoplastni kromatogram: (kloroform/metanol/25% amonijak 70:40:10)Thin layer chromatogram: (chloroform / methanol / 25% ammonia 70:40:10)

Rf=0,44Rf = 0.44

-35Primer 23: oktadecil-(1-metilkinuklidin-3-il)-fosfat-35Example 23: Octadecyl- (1-methylquinuclidin-3-yl) -phosphate

C26H52NO4P (473,68) * 2 H20C26H52NO4P (473.68) * 2 H 2 0

Priprava je analogna primeru 5 iz 18,3 g (67,5 mmol) oktadekanola, 7,0 ml (75 mmol) fosforoksiklorida, 18 + 20 ml piridina in 28,3 g (90 mmol)The preparation is analogous to Example 5 of 18.3 g (67.5 mmol) of octadecanol, 7.0 ml (75 mmol) of phosphoroxychloride, 18 + 20 ml of pyridine and 28.3 g (90 mmol)

3-hidroksi-1 -metilkinuklidinskega tosilata.3-hydroxy-1-methylquinuclidine tosylate.

Čiščenje z raztopitvijo v 96% etanolu in z obdelavo z ionskim izmenjevalcem amberlitom MB 3.Purification by dissolving in 96% ethanol and treating with MB 3 amberlite ion exchanger.

Izkoristek: 18,4 g (57%)Yield: 18.4 g (57%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 61,27% ed: 61.27% 11,07% 11,07% 2,75% 2.75% izr.: 61,27% 61.27% 10,91% 10.91% 2,45% 2.45% 61,95% 61,95% 11,23% 11,23% 2,51% 2.51%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat v 25% amonijaku 70:40:10)Thin layer chromatogram: (chloroform / methanol / 1 M sodium acetate in 25% ammonia 70:40:10)

Rf=0,37 (1 -butanol/led ocetna kislina/voda 40:10:10)Rf = 0.37 (1-butanol / ice acetic acid / water 40:10:10)

Rf=0,13Rf = 0.13

-36Primer 24: heksadecil-(1,1 -dimetiltropanio-4-il)-fosfat-36Example 24: Hexadecyl- (1,1-dimethyltropanyl-4-yl) -phosphate

C25H50NO4P (459,654) * H20C25H50NO4P (459.654) * H 2 0

Priprava je analogna primeru 5 iz 12,1 g (50 mmol) heksadekanola, 5,1 ml (55 mmol) fosforoksiklorida, 17 + 40 ml piridina in 21,3 g (65 mmol)The preparation is analogous to Example 5 of 12.1 g (50 mmol) of hexadecanol, 5.1 ml (55 mmol) of phosphoroxychloride, 17 + 40 ml of pyridine and 21.3 g (65 mmol)

4-hidroksi-1,1 -dimetiltropanijevega tosilata.4-hydroxy-1,1-dimethyltropane tosylate.

Čiščenje z raztopitvijo v 96% etanolu, z obdelavo z ionskim izmenjevalcem amberlitom MB 3 in prekristalizacijo z acetonom.Purification by dissolution in 96% ethanol, treatment with MB 3 ion-exchange amberlite and recrystallization with acetone.

Izkoristek: 11,3 g (49%)Yield: 11.3 g (49%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 62,86% ed: 62.86% 10,97% 10.97% 2,93% 2.93% izr.: 62,45% calc .: 62.45% 11,52% 11.52% 2,82% 2.82% 62,58% 62,58% 11,52% 11.52% 2,75% 2.75%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat v 25% amonijaku 70:40:10)Thin layer chromatogram: (chloroform / methanol / 1 M sodium acetate in 25% ammonia 70:40:10)

Rf=0,28Rf = 0.28

-37Primer 25: oktadecil-(1,1 -dimetiltropanio-4-il)-fosfat-37Example 25: Octadecyl- (1,1-dimethyltropanyl-4-yl) -phosphate

C27H54NO4P (487,708)C27H54NO4P (487,708)

Priprava je analogna primeru 5 iz 13,5 g (50 mmol) oktadekanola, 5,1 ml (55 mmol) fosforoksiklorida, 17 + 20 ml piridina in 21,3 g (65 mmol) 4-hidroksi-1,1-dimetiltropanijevega tosilata.The preparation is analogous to Example 5 of 13.5 g (50 mmol) of octadecanol, 5.1 ml (55 mmol) of phosphoroxychloride, 17 + 20 ml of pyridine and 21.3 g (65 mmol) of 4-hydroxy-1,1-dimethyltropane tosylate .

Čiščenje z raztopitvijo v 96% etanolu in z obdelavo z ionskim izmenjevalcem amberlitom MB 3.Purification by dissolving in 96% ethanol and treating with MB 3 amberlite ion exchanger.

Izkoristek: 10,7 g (44%)Yield: 10.7 g (44%)

Elementarna analiza:Elemental analysis:

C C H H N N izm.: 66,49% ed: 66.49% 11,16% 11,16% 2,87% 2.87% izr.: 65,72% 65.72% 11,48% 11,48% 2,64% 2.64% 66,27% 66,27% 11,78% 11,78% 2,65% 2.65%

Tankoplastni kromatogram: (kloroform/metanol/1 M natrijev acetat v 25% amonijaku 70:40:10)Thin layer chromatogram: (chloroform / methanol / 1 M sodium acetate in 25% ammonia 70:40:10)

Rf=0,22Rf = 0.22

Za:For:

ASTA MEDICA Aktiengesellschaft, NemčijaASTA MEDICA Aktiengesellschaft, Germany

Claims (5)

1. Spojine s splošno formulo I1. Compounds of general formula I R - X - A - P - O - (CH2)y - CHX (CH2)m) R1 R - X - A - P - O - (CH2) y - CH X (CH2) m) R 1 X (CteV X2 v kateri je R ravnoverižni ali razvejani alkilni ostanek z 10 do 24 ogljikovimi atomi, ki lahko vsebuje tudi eno do tri dvojne ali trojne vezi, R1 in R2 neodvisno drug od drugega vsebujeta vodik ali vsak en ravnoverižen, razvejan cikličen nasičen ali nenasičen alkilni ostanek z 1 do 6 ogljikovimi atomi, ki lahko vsebujeta tudi eno skupino CI-, OHali NH2- in pri čemer sta dva ta ostanka lahko tudi spojena v obroč,X (CteV X 2 in which R is a straight or branched alkyl residue of 10 to 24 carbon atoms, which may also contain one to three double or triple bonds, R 1 and R 2 independently of one another contain hydrogen or each straight, branched a cyclic saturated or unsaturated alkyl radical having from 1 to 6 carbon atoms, which may also contain one group of CI-, OH or NH 2 - and two of these residues may also be fused into a ring, A je enostavna vez ali ena od skupin s formulamiA is a simple bond or one of a group of formulas -CH2-CH2-CH2-O- (II)-CH2-CH2-CH2-O- (II) CH2 - CH2 - O - (III)CH 2 - CH 2 - O - (III) - CH2 - CH - O - (IV) I ch3 - CH 2 - CH - O - (IV) I ch 3 S-(CH2)8-O-(V)S- (CH 2 ) 8-O- (V) - CH - CH - CH2 - O I \- CH - CH - CH2 - O I \ H2C O \ ch2 x/ (VI)H 2 CO \ ch 2 x / (VI) -39pri čemer so skupine (II) do (VI) orientirane tako, da je kisikov atom zvezan s fosforjevim atomom vezi (I) in je X kisikov ali žveplov atom ali NH, če je A enostavna vez ali pa kisikov ali žveplov atom, če je A ena od skupin (II) do (IV), kar pomeni, da je y enako 0 ali enemu naravnemu številu med 1 in 3, m in n sta neodvisno drug od drugega naravni števili, določeni z m + n = 2 do 8.-39 wherein groups (II) to (VI) are oriented so that the oxygen atom is bonded to the phosphorus bond atom (I) and X is an oxygen or sulfur atom or NH if A is a simple bond or an oxygen or sulfur atom if A is one of groups (II) to (IV), which means that y is 0 or one integer between 1 and 3, m and n are independently integers defined by zm + n = 2 to 8. 2. Spojine po zahtevku 1, označene s tem, da X pomeni kisikov atom.Compounds according to claim 1, characterized in that X represents an oxygen atom. 3. Spojine po zahtevkih 1 ali 2, označene s tem, da A pomeni enostavno vez. 4 Compounds according to claims 1 or 2, characterized in that A represents a simple bond. 4 4. Spojine po zahtevkih 1 do 3, označene s tem, da sta R1 in R2 vsakokrat metilni skupini.Compounds according to claims 1 to 3, characterized in that R 1 and R 2 are each methyl groups. -405. Oktadecil - (1,1-dimetilpiperidin - 4- il) - fosfat, oktadecil - (1,1dimetilheksahidroazepino - 4- il) - fosfat.-405. Octadecyl - (1,1-dimethylpiperidin-4-yl) -phosphate, octadecyl- (1,1-dimethylhexahydroazepino-4-yl) -phosphate. 6. Postopek za pripravo spojine po enem od zahtevkov 1 do 5, označen s tem, da se doseže, da spojina splošne formuleA process for the preparation of a compound according to any one of claims 1 to 5, characterized in that the compound of the general formula R-X-A-H (VII) v kateri imajo R, X in A v zahtevku 1 navedene pomene, reagira s fosforoksitrikloridom v navzočnosti primerne pomožne baze za reakcijo z ali brez topila in se nato s spojino splošne formuleR-X-A-H (VII) in which R, X and A have the meanings given in claim 1 is reacted with phosphoroxytrichloride in the presence of a suitable auxiliary base for reaction with or without solvent and then with a compound of the general formula HO - (CH2)y - CHHO - (CH 2) y - CH
SI9300365A 1992-07-11 1993-07-09 New alkenes and alkines phoshat derivates, process for their preparation and use thereof as medicine SI9300365B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4222910A DE4222910A1 (en) 1992-07-11 1992-07-11 New phospholipid derivatives

Publications (2)

Publication Number Publication Date
SI9300365A true SI9300365A (en) 1994-03-31
SI9300365B SI9300365B (en) 2002-02-28

Family

ID=6463031

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300365A SI9300365B (en) 1992-07-11 1993-07-09 New alkenes and alkines phoshat derivates, process for their preparation and use thereof as medicine

Country Status (31)

Country Link
EP (1) EP0579939B1 (en)
JP (1) JP3311431B2 (en)
KR (1) KR100297180B1 (en)
CN (1) CN1039012C (en)
AT (1) ATE176477T1 (en)
AU (1) AU664101B2 (en)
BR (1) BR9302809A (en)
CA (2) CA2511753C (en)
CZ (1) CZ290863B6 (en)
DE (2) DE4222910A1 (en)
DK (1) DK0579939T3 (en)
EE (1) EE03140B1 (en)
ES (1) ES2129053T3 (en)
FI (1) FI111262B (en)
GR (1) GR3029602T3 (en)
HR (1) HRP931046B1 (en)
HU (1) HU218783B (en)
IL (1) IL106289A (en)
LT (1) LT3113B (en)
LV (1) LV10870B (en)
MX (1) MX9304133A (en)
NO (1) NO306468B1 (en)
PL (3) PL177811B1 (en)
RU (1) RU2108336C1 (en)
SG (1) SG46249A1 (en)
SI (1) SI9300365B (en)
SK (1) SK283827B6 (en)
TW (1) TW304956B (en)
UA (1) UA40567C2 (en)
YU (1) YU49079B (en)
ZA (1) ZA934971B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080161251A1 (en) 2005-01-21 2008-07-03 Astex Therapeutics Limited Pharmaceutical Compounds
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
AR058397A1 (en) 2005-12-19 2008-01-30 Zentaris Gmbh DERIVATIVES OF ALQUILFOSFOLIPIDOS WITH REDUCED CYTOTOXICITY AND USES OF THE SAME
EP1869981A1 (en) * 2006-06-21 2007-12-26 Staatliches Weinbauinstitut Freiburg Alkylphospholipids and lysophospholipids for controlling plant pathogens
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444766A (en) * 1980-10-21 1984-04-24 Boehringer Mannheim Gmbh Sulfur-containing phospholipid compounds and therapeutic compositions
JPS5984824A (en) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd Antitumor agent
DE3530767A1 (en) * 1985-08-28 1987-03-12 Max Planck Gesellschaft AGENT AGAINST MULTIPLE Sclerosis
IE59777B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicaments
DE3765502D1 (en) * 1986-07-14 1990-11-15 Nippon Chemiphar Co GLYCEROL DERIVATIVE AND ANTI-HYPERTENSIVE AGENT.
US4962096A (en) * 1987-03-24 1990-10-09 Nippon Chemiphar Co., Ltd. Heterocyclic glycerol derivatives and their use as anti-hypertensive agents
DE3906952A1 (en) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3- (C (DOWN ARROW)) (DOWN ARROW) (DOWN ARROW) 6 (DOWN ARROW) -C (DOWN ARROW) 1 (DOWN ARROW) (DOWN ARROW) 8 (DOWN ARROW)) ALKANSULFINYL AND 2 SULPHONE -METHOXYMETHYL-PROPYL) - (2-TRIMETHYLAMMONIO-ETHYL) PHOSPHATES, METHOD FOR PRODUCING THE MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3942933A1 (en) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh USE OF ALKYLPHOSPHOLIPIDES AS ANTIVIRAL MEDICINAL PRODUCTS AND NEW PHOSPHOLIPID DERIVATIVES
DE4114586A1 (en) * 1991-05-04 1992-11-05 Boehringer Mannheim Gmbh MEDICINAL PRODUCTS CONTAINING AZACYCLODIPHOSPHONIC ACID DERIVATIVES, NEW AZACYCLODIPHOSPHONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
YU49079B (en) 2003-08-29
DE59309355D1 (en) 1999-03-18
ZA934971B (en) 1994-02-01
ATE176477T1 (en) 1999-02-15
TW304956B (en) 1997-05-11
FI933165A (en) 1994-01-12
CA2511753C (en) 2007-09-25
UA40567C2 (en) 2001-08-15
EP0579939B1 (en) 1999-02-03
SK283827B6 (en) 2004-02-03
HU218783B (en) 2000-12-28
CA2100228C (en) 2006-01-24
HUT64548A (en) 1994-01-28
IL106289A0 (en) 1994-04-12
ES2129053T3 (en) 1999-06-01
NO932502L (en) 1994-01-12
FI933165A0 (en) 1993-07-09
DE4222910A1 (en) 1994-01-13
LTIP620A (en) 1994-07-15
RU2108336C1 (en) 1998-04-10
MX9304133A (en) 1994-04-29
NO306468B1 (en) 1999-11-08
HRP931046A2 (en) 1997-04-30
NO932502D0 (en) 1993-07-08
SG46249A1 (en) 1998-02-20
PL299624A1 (en) 1994-02-21
DK0579939T3 (en) 1999-09-20
CZ290863B6 (en) 2002-11-13
EP0579939A1 (en) 1994-01-26
BR9302809A (en) 1994-03-15
LV10870B (en) 1996-06-20
EE03140B1 (en) 1998-12-15
GR3029602T3 (en) 1999-06-30
JPH0733791A (en) 1995-02-03
PL175607B1 (en) 1999-01-29
PL173388B1 (en) 1998-02-27
IL106289A (en) 2000-06-01
FI111262B (en) 2003-06-30
JP3311431B2 (en) 2002-08-05
KR100297180B1 (en) 2001-11-30
CA2100228A1 (en) 1994-01-12
CZ124993A3 (en) 1995-03-15
SK67093A3 (en) 1995-03-08
KR940002265A (en) 1994-02-17
AU664101B2 (en) 1995-11-02
CN1084175A (en) 1994-03-23
LV10870A (en) 1995-10-20
PL177811B1 (en) 2000-01-31
CA2511753A1 (en) 1994-01-12
CN1039012C (en) 1998-07-08
YU47393A (en) 1997-08-22
HRP931046B1 (en) 2000-06-30
HU9301992D0 (en) 1993-09-28
LT3113B (en) 1994-12-27
SI9300365B (en) 2002-02-28
AU4186493A (en) 1994-01-13

Similar Documents

Publication Publication Date Title
US3074992A (en) Novel cyclic phosphoric acid ester amides, and the production thereof
US4493832A (en) Certain glycerol-phosphoryl choline derivatives, compositions containing same and method of using same
Khorana et al. 465. Studies on phosphorylation. Part XI. The reaction between carbodi-imides and acid esters of phosphoric acid. A new method for the preparation of pyrophosphates
US4562179A (en) Phospholipid derivatives, and pharmaceutical composition of the same
DK167808B1 (en) Methylenebisphosphonic acid derivative, process for preparing it, and pharmaceutical composition which comprises these derivatives
SI9300365A (en) New alkenes and alkines phoshat derivates, process for their preparation and use thereof as medicine
JPS60260581A (en) 1-(hydroxymethyl)-1,6,7,11b-tetrahydro-2h,4h-(1,3)oxazino- or -thiazino(4,3-a)isoquinoline derivative
AU2019324521A1 (en) Method for preparing 2-((3R)-3-methylmorpholin-4-yl)-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine
JP2869572B2 (en) Method for producing phosphatidylcholine derivative
US4874779A (en) Mitomycin phosphate derivatives
DE3505576A1 (en) OXICAME ANTI-INFLAMMATORY AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH ANTI-PRIME
JPH0240648B2 (en) KETSUSHOBANKATSUSEIINSHOKUSEIZAI
US3808333A (en) O-(2-amino-4-methyl-pyrimidyl-6)-thiophosphoroamidate
US3169904A (en) Triazine derivatives possessing aphicidal properties
SU858566A3 (en) Method of preparing quaternary derivatives of xanthinylalkylnortropin
HU220593B1 (en) Phosphonium, arzonium and stibonium inner salts of phospholipid derivatives medicaments comprising the same and process for producing them
CS219347B2 (en) Method of preparation of the 1-hydroxyaporfin derivative
US3180793A (en) Insect sterilizing process
US2731469A (en) N-dialkylaminoalkyl derivatives of diarylisonicotinamides
US3220922A (en) Amino-triazol derivatives
US3849559A (en) Tranquilizer composition and method of treatment
US3057850A (en) Anti-tumour compound
US2700045A (en) 2-(2'-imidazoline-2'-thiomethyl)-5-hydroxy-4-pyrone, 2-(2'-imidazoline-2'-thiomethyl)-5-alkoxy-4-pyrones and salts thereof
CA2085520C (en) Stable hexahydrate of etoposide 4'-phosphate disodium salt
DK155742B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF WATER SOLUBLE HYDRAZONS OF 3-FORMYL RIFAMYCINE SV

Legal Events

Date Code Title Description
IF Valid on the event date
SP73 Change of data on owner

Owner name: ZENTARIS GMBH; DE

Effective date: 20060607

SP73 Change of data on owner

Owner name: AETERNA ZENTARIS GMBH; DE

Effective date: 20100927